Tag: Pfizer sickle cell treatment controversy

news-26092024-043449

Pfizer Withdraws Oxbryta Sickle Cell Treatment from Global Markets

Pfizer, a leading pharmaceutical company, made headlines on Wednesday with the announcement that it would be withdrawing Oxbryta, a medication used to treat sickle cell disease, from all global markets. This decision was prompted...